tiprankstipranks
Bio-Path Holdings Shifts Focus to Metabolic Program
PremiumCompany AnnouncementsBio-Path Holdings Shifts Focus to Metabolic Program
1M ago
Bio-Path outlines rationale for development of BP1001-A
Premium
The Fly
Bio-Path outlines rationale for development of BP1001-A
1M ago
Bio-Path Holdings Expands DNAbilize® Technology Applications
Premium
Company Announcements
Bio-Path Holdings Expands DNAbilize® Technology Applications
2M ago
Bio-Path Holdings Raises $4M Through Private Placement
PremiumCompany AnnouncementsBio-Path Holdings Raises $4M Through Private Placement
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Bio-Path prices $4.0M at-the-market offering for $0.87 per share
Premium
The Fly
Bio-Path prices $4.0M at-the-market offering for $0.87 per share
3M ago
Bio-Path provides update on ongoing Phase 1/1b trial of BP1001-A
PremiumThe FlyBio-Path provides update on ongoing Phase 1/1b trial of BP1001-A
5M ago
Eleven option delistings on August 19th
Premium
The Fly
Eleven option delistings on August 19th
5M ago
Bio-Path reports Q2 EPS ($1.16) vs ($10.64) last year
Premium
The Fly
Bio-Path reports Q2 EPS ($1.16) vs ($10.64) last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100